{"id":"W4386008142","doi":"10.1093/crocol/otad034","title":"Practical Primer Addressing Real-World Use Scenarios of Subcutaneous Vedolizumab in Ulcerative Colitis and Crohn’s Disease: Post Hoc Analyses of VISIBLE Studies","year":2023,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Takeda Pharmaceuticals U.S.A.","keywords":"Vedolizumab; Medicine; Ulcerative colitis; Dosing; Internal medicine; Post-hoc analysis; Crohn's disease; Gastroenterology; Clinical trial; Maintenance therapy; Disease; Chemotherapy","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002287264,0.0002675021,0.0004622425,0.0002572806,0.0001211881,0.00005947295,0.0001347648,0.0001163292,0.0000328082],"category_scores_gemma":[0.001196741,0.000276641,0.000130512,0.0003714479,0.0005906034,0.00003566188,0.0002870044,0.0001271471,0.000005819283],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007269617,"about_ca_system_score_gemma":0.0006095265,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005380405,"about_ca_topic_score_gemma":0.003987115,"domain_scores_codex":[0.9978474,0.000329729,0.0005679808,0.0005212215,0.0002799879,0.000453664],"domain_scores_gemma":[0.9982845,0.0002253658,0.0002642463,0.0004736437,0.0005234657,0.0002287929],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1226726,0.002638166,0.4744092,0.008178745,0.004877051,0.09662049,0.007163337,0.001715692,0.2343514,0.01023343,0.02869998,0.008439885],"study_design_scores_gemma":[0.0009636257,0.0001758211,0.9894516,0.0002793875,0.0001557487,0.00003037539,0.0005537781,0.0001318827,0.007361124,0.0001080666,0.0005058178,0.0002828139],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9977614,0.0007047647,0.000006010395,0.0001168103,0.00009061053,0.0005254729,0.0005225128,0.00002673868,0.000245712],"genre_scores_gemma":[0.9972633,0.001256385,0.000278602,0.00008567246,0.00008527142,0.00006662575,0.0001876467,0.00004244114,0.000734085],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5150424,"threshold_uncertainty_score":0.9999686,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07314988302568722,"score_gpt":0.3828411585899901,"score_spread":0.3096912755643029,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}